[HTML][HTML] IGF1R signalling and its inhibition

J Riedemann, VM Macaulay - Endocrine-related cancer, 2006 - erc.bioscientifica.com
The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase that is frequently
overexpressed by tumours, and mediates proliferation and apoptosis protection. IGF …

Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

H Werner, R Sarfstein, I Bruchim - Expert opinion on investigational …, 2019 - Taylor & Francis
Introduction: The insulin-like growth factors (IGFs) are a family of secreted peptide hormones
with important roles in different cellular and organism functions. The biological activities of …

The type 1 insulin-like growth factor receptor pathway

MM Chitnis, JSP Yuen, AS Protheroe, M Pollak… - Clinical cancer …, 2008 - AACR
Research conducted over the past two decades has shown the importance of the type 1
insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to …

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

EA Bohula, MP Playford, VM Macaulay - Anti-cancer drugs, 2003 - journals.lww.com
The type 1 insulin-like growth factor receptor (IGF1R) is overexpressed by many tumors, and
mediates growth, motility and protection from apoptosis. Inhibition of IGF1R expression or …

Disrupting insulin and IGF receptor function in cancer

J Cao, D Yee - International journal of molecular sciences, 2021 - mdpi.com
The insulin and insulin-like growth factor (IGF) system plays an important role in regulating
normal cell proliferation and survival. However, the IGF system is also implicated in many …

Targeting the insulin-like growth factor-1 receptor in human cancer

A Arcaro - Frontiers in pharmacology, 2013 - frontiersin.org
The insulin-like growth factor (IGF) signaling system plays a crucial role in human cancer
and the IGF-1 receptor (IGF-1R) is an attractive drug target against which a variety of novel …

The insulin-like growth factor 1 receptor in cancer: old focus, new future

H Hartog, J Wesseling, HM Boezen… - European journal of …, 2007 - Elsevier
The importance of insulin-like growth factor 1 receptor (IGF-1R) signalling in malignant
behaviour of tumour cells is well established. Currently, development of drugs targeting the …

Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy

J Zha, MR Lackner - Clinical Cancer Research, 2010 - AACR
Signaling through the insulin-like growth factor receptor (IGF-1R) is required for neoplastic
transformation by a number of oncogenes, and preclinical validation studies have suggested …

Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer

DR Clemmons - Nature reviews Drug discovery, 2007 - nature.com
Insulin-like growth factor 1 (IGF1) is a polypeptide hormone that has a high degree of
structural similarity to human proinsulin. Owing to its ubiquitous nature and its role in …

Targeting the insulin-like growth factor network in cancer therapy

I Heidegger, A Pircher, H Klocker… - Cancer biology & …, 2011 - Taylor & Francis
During the last decades, changes in the insulin-like growth factor (IGF) signaling have been
related to the pathogenesis of cancer. Therefore, IGFs became highly attractive therapeutic …